| 33400 |
(±)10-HDoHE
|
|
90780-50-0 |
≥98%
|
|
|
|
12.843563535912
|
-10-hdohe
|
10-hydroxy Docosahexaenoic Acid
|
racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)10-HDoHEs (+/-)HDoHEs neurochemistry |
12.843563535912
|
| 51511 |
(±)11,12-DHET
|
|
- |
≥98%
|
|
|
|
49.601602209945
|
-11-12-dhet
|
(±)11,12-DiHETrE
|
epoxides epoxygenases DHTs hydrolases (+/-)11,12-DiHETrEs |
49.601602209945
|
| 10007266 |
(±)11,12-DHET Lipid Maps MS Standard
|
|
- |
≥98%
|
|
|
2009-02-11
|
52.514077348066
|
-11-12-dhet-lipid-maps-ms-standard
|
(±)11,12-DiHETrE
|
epoxides epoxygenases DHTs hydrolases (+/-)11,12-DiHETrEs MS mass spectrometry standards |
52.514077348066
|
| 50511 |
(±)11(12)-EET
|
|
123931-40-8 |
≥95%
|
|
|
|
53.453693764799
|
-11-12-eet
|
(±)11(12)-EpETrE
|
epoxides epoxygenases 11,12-EETs cytochrome P450 (+/-)11,12-EpETrEs (+/-)11(12)-EpETrEs |
53.453693764799
|
| 10007262 |
(±)11(12)-EET Lipid Maps MS Standard
|
|
- |
≥98%
|
|
|
2009-02-11
|
19.253825966851
|
-11-12-eet-lipid-maps-ms-standard
|
(±)11(12)-EpETrE
|
epoxides epoxygenases 11,12-EETs cytochrome P450 (+/-)11,12-EpETrEs (+/-)11(12)-EpETrEs MS mass spectrometry standards |
19.253825966851
|
| 50510 |
(±)11(12)-EET methyl ester
|
|
- |
≥98%
|
|
|
|
19.511174033148
|
-11-12-eet-methyl-ester
|
(±)11(12)-EpETrE methyl ester
|
epoxides epoxygenases 11,12-EETs cytochrome P450 (+/-)11(12)-EpETrEs (+/-)11,12-EpETrEs esters |
19.511174033148
|
| 10462 |
11(12)-EpETE
Exclusive |
|
504435-15-8 |
≥98%
|
|
✓ |
2010-10-28
|
7.280628453038
|
11-12-epete
|
11,12-EEQ; 11,12-Epoxyeicosatetraenoic Acid
|
eicosapentaenoic acids EPAs epoxyeicosatetraenoic EpETE EETeTr cytochromes P450 epoxygenases CYP450 10-[3-2Z,5Z-octadien-1-yl-2-oxiranyl]-5Z,8Z-decadienoic acid 11,12-epoxyeicosatrienoic acid |
7.280628453038
|
| 33450 |
(±)11-HDoHE
|
|
87018-59-5 |
≥98%
|
|
|
|
11.408922651933
|
-11-hdohe
|
11-hydroxy Docosahexaenoic Acid
|
racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)11-HDoHEs (+/-)HDoHEs neurochemistry |
11.408922651933
|
| 37500 |
(±)11-HEDE
|
|
5598-37-8 |
≥98%
|
|
|
|
0.337679558011
|
-11-hede
|
|
racemic hydroxy fatty acids autoxidation (+/-)11-HEDEs (+/-)-HEDEs (+/-)HEDEs |
0.337679558011
|
| 32500 |
(±)11-HEPE
|
|
99217-78-4 |
≥98%
|
|
|
|
7.138500394633
|
-11-hepe
|
|
racemic hydroxy acids EPA autoxidation (+/-)11-HEPEs eicosapentanoic fatty (+/-)-HEPEs (+/-)HEPEs |
7.138500394633
|
| 34500 |
(±)11-HETE
|
|
73804-65-6 |
≥98%
|
|
|
|
19.177665745856
|
-11-hete
|
|
racemic hydroxy acids autoxidation (+/-)11-HETEs fatty (+/-)-HETEs (+/-)HETEs |
19.177665745856
|
| 37505 |
11(R)-HEDE
|
|
- |
≥98%
|
|
|
|
0.216500920810
|
11-r-hede
|
|
hydroxy fatty acids cyclooxygenases COX PGHS prostaglandin synthases 11R-HEDEs 11-HEDEs 11(R)HEDEs eicosadienoic 11(R)-HEDEs |
0.216500920810
|
| 32505 |
11(R)-HEPE
Exclusive |
|
109430-11-7 |
≥98%
|
|
✓ |
|
3.604972375691
|
11-r-hepe
|
|
hydroxy acids EPA 11R-HEPEs 11(R)-HEPEs 11-HEPEs eicosapentanoic 11-lipoxygenases fatty 11(R)HEPEs 11(R)-LO 11(R)LO 11-LOs 11R-LO |
3.604972375691
|
| 34505 |
11(R)-HETE
|
|
73347-43-0 |
≥98%
|
|
|
|
2.687237569061
|
11-r-hete
|
|
hydroxy acids 11R-HETEs 11-HETEs fatty 11(R)-HETEs 11(R)HETEs 11(R)-LO 11R-LO 11(R)LO 11-LOs 11-lipoxygenases |
2.687237569061
|
| 37510 |
11(S)-HEDE
|
|
330800-90-3 |
≥98%
|
|
|
|
0.090883977900
|
11-s-hede
|
|
hydroxy fatty acids 11S-HEDEs 11-HEDEs 11(S)HEDEs eicosadienoic 11(S)-HEDEs |
0.090883977900
|
| 32510 |
11(S)-HEPE
|
|
- |
≥98%
|
|
|
|
5.624033149171
|
11-s-hepe
|
|
hydroxy fatty acids EPA 11-HEPEs 11S-HEPEs 11(S)-HEPEs eicosapentanoic 11(S)HEPES cyclooxygenases COX2 PGHS2 COX-1 PGHS-1 prostaglandin synthases |
5.624033149171
|
| 34510 |
11(S)-HETE
|
|
54886-50-9 |
≥98%
|
|
|
|
5.033743093923
|
11-s-hete
|
|
hydroxy fatty acids 11-HETEs 11S-HETEs 11(S)-HETEs 11(S)HETEs 11-LOs 11-lipoxygenases |
5.033743093923
|
| 10007246 |
11(S)-HETE Lipid Maps MS Standard
|
|
54886-50-9 |
≥98%
|
|
|
2009-02-17
|
6.909779005524
|
11-s-hete-lipid-maps-ms-standard
|
|
hydroxy fatty acids 11-HETEs 11S-HETEs 11(S)-HETEs 11(S)HETEs 11-LOs 11-lipoxygenases MS mass spectrometry standards |
6.909779005524
|
| 10009832 |
(±)12,13-DiHOME
|
|
263399-35-5 |
≥98%
|
|
|
2007-06-26
|
6.070239410681
|
-12-13-dihome
|
Isoleukotoxin diol
|
epoxides epoxygenase leukotoxin cytochrome P450 CYP450 sEH soluble epoxide hydrolase UGT glucuronidation UGT2B7 |
6.070239410681
|
| 10009994 |
(±)12,13-DiHOME-d4
|
|
- |
≥99% deuterated forms (d1-d4)
|
|
|
2007-06-26
|
5.454254143646
|
-12-13-dihome-d4
|
Isoleukotoxin diol-d4
|
epoxides epoxygenase leukotoxin cytochrome P450 CYP450 sEH soluble epoxide hydrolase UGT glucuronidation UGT2B7 mass spectrometry MS deuterated deuterium |
5.454254143646
|
| 52450 |
(±)12(13)-EpOME
|
|
- |
≥98%
|
|
|
|
5.569295580110
|
-12-13-epome
|
iso-Leukotoxin; 12,13-EODE
|
epoxides epoxygenases cytochrome P450 (+/-)12,13-EpOMEs (+/-)12(13)-EpOMEs epoxy fatty acids |
5.569295580110
|
| 10009996 |
(±)12(13)-EpOME-d4
|
|
- |
≥99% deuterated forms (d1-d4)
|
|
|
2007-06-04
|
2.316795580110
|
-12-13-epome-d4
|
iso-Leukotoxin-d4; 12,13-EODE-d4
|
epoxides epoxygenases cytochrome P450 (+/-)12,13-EpOMEs (+/-)12(13)-EpOMEs epoxy fatty acids |
2.316795580110
|
| 32540 |
(±)12-HEPE
Exclusive |
|
81187-21-5 |
≥98%
|
|
✓ |
|
12.861635359116
|
-12-hepe
|
|
racemic monohydroxy acids EPA autoxidation (+/-)12-HEPEs eicosapentanoic fatty (+/-)-HEPEs (+/-)HEPEs polyunsaturated |
12.861635359116
|
| 34550 |
(±)12-HETE
|
|
71030-37-0 |
≥98%
|
|
|
|
46.828047882136
|
-12-hete
|
|
racemic hydroxy acids autoxidation (+/-)12-HETEs fatty (+/-)-HETEs (+/-)HETEs |
46.828047882136
|
| 10138 |
(±)12-HpETE
|
|
71030-35-8 |
≥96%
|
|
|
|
33.893690607734
|
-12-hpete
|
|
(±)12-HpETEs hydroperoxides (±)12HpETEs hydroperoxy arachidonic fatty acids racemic hydroxy fatty acids autoxidation (±)-HpETEs (±)HpETEs |
33.893690607734
|
| 34580 |
12-OxoETE
|
|
108437-64-5 |
>90%
|
|
|
|
33.932607734807
|
12-oxoete
|
12-KETE
|
HETEs metabolites 12-KETEs chemotactic 12-OxoETEs fatty acids oxo-acids 12-oxo-ETEs |
33.932607734807
|
| 10007249 |
12-OxoETE Lipid Maps MS Standard
|
|
108437-64-5 |
≥90%
|
|
|
2009-02-18
|
25.686675874769
|
12-oxoete-lipid-maps-ms-standard
|
12-KETE
|
HETEs metabolites 12-KETEs chemotactic 12-OxoETEs fatty acids oxo-acids 12-oxo-ETEs MS mass spectrometry standards |
25.686675874769
|
| 88520 |
12-oxo Phytodienoic Acid
|
|
85551-10-6 |
>95%
|
|
|
2010-08-05
|
14.388447513812
|
12-oxo-phytodienoic-acid
|
12-oxo PDA; OPDA
|
jasmonic acids plants growth regulators linolenic defense oxylipins pests pathogens opda 12 opda 12-opda 12-oxo pda 12 oxo 12-oxo phytodienoics acids 12oxo Fatty Acids, Polyunsaturated
Acids Polyunsaturated Fatty
Polyunsaturated Fatty Acids
Fatty Acids Unsaturated
Acids Unsaturated Fatty
Unsaturated Fatty Acids |
14.388447513812
|
| 32545 |
12(R)-HEPE
|
|
109430-12-8 |
≥98%
|
|
|
|
10.531482504604
|
12-r-hepe
|
|
hydroxy fatty acids EPA eicosapentaenoic 12-lipoxygenases sea urchins 12-LOs 12(R)-HEPEs 12R-HEPEs 12-HEPEs 12(R)HEPEs |
10.531482504604
|
| 34560 |
12(R)-HETE
|
|
82337-46-0 |
≥98%
|
|
|
|
37.718508287292
|
12-r-hete
|
|
hydroxy acids 12-LOs sea urchin 12R-HETEs 12-HETEs fatty 12(R)-HETEs 12(R)HETEs 12-lipoxygenases |
37.718508287292
|
| 10007247 |
12(R)-HETE Lipid Maps MS Standard
|
|
82337-46-0 |
≥98%
|
|
|
2009-02-17
|
20.815497237568
|
12-r-hete-lipid-maps-ms-standard
|
|
hydroxy acids 12-LOs sea urchin 12R-HETEs 12-HETEs fatty 12(R)-HETEs 12(R)HETEs 12-lipoxygenases MS mass spectrometry standards |
20.815497237568
|
| 32550 |
12(S)-HEPE
|
|
116180-17-7 |
≥98%
|
|
|
|
24.682912391476
|
12-s-hepe
|
|
hydroxy fatty acids EPA 12S-HEPEs 12(S)-HEPEs 12-HEPEs eicosapentaenoic 12(S)HEPEs 12-lipoxygenases 12-LOs |
24.682912391476
|
| 34570 |
12(S)-HETE
|
|
54397-83-0 |
≥98%
|
|
|
|
90.660232044199
|
12-s-hete
|
|
12-HETEs 12-LOs pig leukocytes platelets human 12S-HETEs 12-lipoxygenases 12(S)-HETEs porcine hydroxy fatty acids 12(S)HETEs |
90.660232044199
|
| 334570 |
12(S)-HETE-d8
|
|
84807-90-9 |
≥99% deuterated product
|
|
|
|
47.663911602209
|
12-s-hete-d8
|
|
GC/MS deuterium isotopes 12-HETE-d8 standards12S-HETE-d8 deuterated GC-MS LC/MS LC-MS 12-HETEs 12(S)-HETEs 12S-HETEs 12(S)HETEs hydroxy fatty acids 12(S)HETE-d8 mass spectrometry |
47.663911602209
|
| 10007248 |
12(S)-HETE Lipid Maps MS Standard
|
|
54397-83-0 |
≥98%
|
|
|
2009-02-18
|
28.094574585635
|
12-s-hete-lipid-maps-ms-standard
|
|
12-HETEs 12-LOs pig leukocytes platelets human 12S-HETEs 12-lipoxygenases 12(S)-HETEs porcine hydroxy fatty acids 12(S)HETEs MS mass spectrometry standards |
28.094574585635
|
| 34590 |
12(S)-HHTrE
|
|
54397-84-1 |
≥97%
|
|
|
|
52.589631675875
|
12-s-hhtre
|
12(S)-HHT
|
platelets thromboxanes hydroxy acids 12S-HHTrEs 12-HHTrEs fatty atherosclerosis 12(s)-hhtre 12(s)-hhtre |
52.589631675875
|
| 10007250 |
12(S)-HHTrE Lipid Maps MS Standard
|
|
54397-84-1 |
≥97%
|
|
|
2009-02-26
|
35.295558011050
|
12-s-hhtre-lipid-maps-ms-standard
|
12-HHT
|
platelets thromboxanes hydroxy acids 12S-HHTrEs 12-HHTrEs fatty atherosclerosis MS mass spectrometry standards |
35.295558011050
|
| 42550 |
12(S)-HpEPE
|
|
103239-14-1 |
≥96%
|
|
|
|
9.927908445146
|
12-s-hpepe
|
|
hydroperoxides EPA 12-HpEPEs 12S-HpEPEs 12-LOs 12-lipoxygenases monohydroperoxy 12(S)-HpEPEs 12(S)HpEPEs eicosapentaenoic fatty acids polyunsaturated |
9.927908445146
|
| 44570 |
12(S)-HpETE
|
|
71774-10-2 |
≥98%
|
|
|
|
22.262596685083
|
12-s-hpete
|
|
12-LOs 12-HpETEs 12S-HpETEs hydroperoxides 12-lipoxygenases 12(S)-HpETEs monohydroperoxy fatty arachidonic acids polyunsaturated |
22.262596685083
|
| 10007258 |
12(S)-HpETE Lipid Maps MS Standard
|
|
71774-10-2 |
≥98%
|
|
|
2009-02-02
|
18.024519337017
|
12-s-hpete-lipid-maps-ms-standard
|
|
12-LOs 12-HpETEs 12S-HpETEs hydroperoxides 12-lipoxygenases 12(S)-HpETEs monohydroperoxy fatty arachidonic acids polyunsaturated MS mass spectrometry standard |
18.024519337017
|
| 31570 |
12(S)-hydroxy-16-Heptadecynoic Acid
Exclusive |
|
148019-74-3 |
≥98%
|
|
✓ |
|
0.870055248619
|
12-s-hydroxy-16-heptadecynoic-acid
|
|
acetylene inhibitors omega-hydroxylases cytochromes P450 hydroxy fatty acids .omega.-hydroxyases w-hydroxylases inhibits 12S-hydroxy-16-heptadecynoic |
0.870055248619
|
| 10195 |
13-epi-12-oxo Phytodienoic Acid
Exclusive |
|
71606-07-0 |
>95%
|
|
✓ |
|
15.454342541436
|
13-epi-12-oxo-phytodienoic-acid
|
13-epi-12-oxo PDA
|
.alpha.-linolenic alpha-linolenic isomers isomerize 13-epi-12-oxo-PDA jasmonic acids plants growth regulators |
15.454342541436
|
| 33500 |
(±)13-HDoHE
|
|
90780-53-3 |
≥98%
|
|
|
|
11.307265193370
|
-13-hdohe
|
13-hydroxy Docosahexaenoic Acid
|
racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)13-HDoHEs (+/-)HDoHEs neurochemistry |
11.307265193370
|
| 38600 |
(±)13-HODE
|
|
73804-64-5 |
≥98%
|
|
|
|
37.389378453039
|
-13-hode
|
|
atherosclerosis LDL oxidized lipids racemic autoxidation (+/-)13-HODEs hydroxy fatty acids (+/-)-HODEs (+/-)HODEs |
37.389378453039
|
| 38601 |
(±)13-HODE cholesteryl ester
|
|
167354-91-8 |
≥98%
|
|
|
|
6.674769797421
|
-13-hode-cholesteryl-ester
|
|
atherosclerosis LDL oxidized lipids autoxidation hydroxy fatty acids (+/-)13-HODEs esters racemic |
6.674769797421
|
| 38620 |
13-OxoODE
|
|
54739-30-9 |
>98%
|
|
|
|
6.162049003122
|
13-oxoode
|
13-KODE
|
13-KODEs fatty metabolites 13-OxoODEs 13-oxo-ODEs oxo-acids deuterateds deuterium mass spectrometry LC-MS LC/MS NAD+ rats colonic cells proliferation oxo-fatty 13-HODEs HODEs NAD dependent dehydrogenase mucosa intra-rectally intrarectally maturation reticulocytes erythrocytes 15-LO 15-lipoxygenase OxoODEs rats NAD+ colonic |
6.162049003122
|
| 338620 |
13-OxoODE-d3
New |
|
- |
≥99% deuterated product
|
|
|
2011-11-11
|
6.663195612138
|
13-oxoode-d3
|
13-KODE-d3
|
13-KODEs fatty metabolites 13-OxoODEs 13-oxo-ODEs oxo-acids deuterateds deuterium mass spectrometry LC-MS LC/MS NAD+ rats colonic cells proliferation oxo-fatty 13-HODEs HODEs NAD dependent dehydrogenase mucosa intra-rectally intrarectally maturation reticulocytes erythrocytes 15-LO 15-lipoxygenase OxoODEs |
6.663195612138
|
| 38605 |
13(R)-HODE
|
|
10219-69-9 |
≥98%
|
|
|
|
18.204723756906
|
13-r-hode
|
|
hydroxy acids 13R-HODEs 13-HODEs fatty 13(R)-HODEs 13(R)HODEs |
18.204723756906
|
| 38606 |
13(R)-HODE cholesteryl ester
|
|
- |
≥98%
|
|
|
|
1.150773480663
|
13-r-hode-cholesteryl-ester
|
|
atherosclerosis LDL oxidized lipids autoxidation hydroxy fatty acids 13-HODEs 13R-HODEs esters |
1.150773480663
|
| 38610 |
13(S)-HODE
|
|
29623-28-7 |
≥98%
|
|
|
|
73.895011838990
|
13-s-hode
|
|
hydroxy fatty acids linoleic metastasis 13-HODEs 13S-HODEs 13(S)-HODEs 13(S)HODEs |
73.895011838990
|
| 38612 |
13(S)-HODE-biotin
|
|
- |
≥98% (may contain trace amounts of free biotin)
|
|
|
|
21.322799263352
|
13-s-hode-biotin
|
|
hydroxy fatty linoleic acids metabolites binding proteins receptors detection 13S-HODE-biotin 13(S)HODE-biotin 13S-HODES 13(S)-HODES 13-HODEs 13(S)HODEs |
21.322799263352
|
| 38611 |
13(S)-HODE cholesteryl ester
|
|
- |
≥98%
|
|
|
|
16.147071823204
|
13-s-hode-cholesteryl-ester
|
|
atherosclerosis LDL oxidized lipids autoxidation hydroxy fatty acids 13-HODEs 13S-HODEs esters 13(S)HODEs 13(S)-HODEs |
16.147071823204
|
| 338610 |
13(S)-HODE-d4
|
|
139408-39-2 |
≥99% deuterated product
|
|
|
|
39.474696132597
|
13-s-hode-d4
|
|
GC/MS deuterium isotopes 13-HODE-d4 standards 13S-HODE-d4 deuterated GC-MS LC/MS LC-MS 13-HODEs 13(S)-HODEs 13S-HODEs 13(S)HODEs hydroxy fatty acids 13(S)HODE-d4 mass spectrometry |
39.474696132597
|
| 10008875 |
13(S)-HODE methyl ester
|
|
109837-85-6 |
≥98%
|
|
|
2006-12-05
|
18.855480662983
|
13-s-hode-methyl-ester
|
|
hydroxy fatty acids methyl esters HODEs 15-LO 15-lipoxygenase metabolites linoleic endothelial cells leukocytes tumors inhibits inhibitors inhibition adhesion endothelium down regulation IRGpIIb/IIIa receptors lipophilic analytical standards |
18.855480662983
|
| 39620 |
13(S)-HOTrE
|
|
87984-82-5 |
≥98%
|
|
|
|
4.362099447513
|
13-s-hotre
|
|
linolenic acids hydroxy metabolites 13S-HOTrEs 13-HOTrEs fatty 13(S)-HOTrEs 13(S)HOTrEs |
4.362099447513
|
| 39610 |
13(S)-HOTrE(γ)
|
|
74784-20-6 |
≥98%
|
|
|
|
5.067016574585
|
13-s-hotre
|
|
linolenic acids metabolites hydroxy 13S-HOTrE.gamma. 13S-HOTrEgamma 13(S)-HOTrE.gamma. 13(S)-HOTrEgamma 13(S)-HOTrE(gamma) 13(S)-HOTrE(.gamma.) 13(S)-HOTrEs 13(S)HOTrEs 13S-HOTrEs 13-HOTrEs fatty 13SHOTrE(gamma) 13S-HOTrE(.gamma.) 13S-HOTrE(g) 13(S)-HOTrE(g) |
5.067016574585
|
| 48610 |
13(S)-HpODE
|
|
33964-75-9 |
>98%
|
|
|
|
84.117219152854
|
13-s-hpode
|
|
linoleic hydroperoxides 13S-HpODEs 13-HpODEs hydroperoxy fatty acids 13(S)-HpODEs |
84.117219152854
|
| 45220 |
13(S)-HpOTrE
Exclusive |
|
67597-26-6 |
≥98%
|
|
✓ |
|
13.287270718232
|
13-s-hpotre
|
|
13-HpOTrEs monohydroperoxy fatty acids hydroperoxides 13S-HpOTrEs 13(S)-HpOTrEs PUFA soybeans LO-2 lipoxygenases linolenic 13S-hydroperoxy-9Z,11E,15Z-octadecatrienoic |
13.287270718232
|
| 45210 |
13(S)-HpOTrE(γ)
Exclusive |
|
121107-97-9 |
≥98%
|
|
✓ |
|
8.536906077348
|
13-s-hpotre
|
|
acids hydroperoxides 13S-HpOTrE.gamma. 13S-HpOTrEgamma 13-HpOTrE.gamma. 13-HpOTrEgamma 13(S)HpOTrE.gamma. 13(S) HpOTrEgamma 13(S)-HpOTrE(g) hydroperoxy soybean lipoxygenase-1 lipoxygenases fatty 13(S)-HpOTrE(gamma) 13(S)-HpOTrE(.gamma.) LOs .gamma.linolenic |
8.536906077348
|
| 51651 |
(±)14,15-DHET
|
|
- |
≥98%
|
|
|
|
25.672803867403
|
-14-15-dhet
|
(±)14,15-DiHETrE
|
epoxides epoxygenases DHTs hydrolases (+/-)14,15-DiHETrEs |
25.672803867403
|
| 10007267 |
(±)14,15-DHET Lipid Maps MS Standard
|
|
- |
>98%
|
|
|
2009-01-06
|
18.497085635359
|
-14-15-dhet-lipid-maps-ms-standard
|
(±)14,15-DiHETrE
|
epoxides epoxygenases DHTs hydrolases (+/-)14,15-DiHETrEs MS mass spectrometry standards |
18.497085635359
|
| 10006998 |
(±)14,15-DiHETE
Exclusive |
|
- |
≥98%
|
|
✓ |
2005-07-13
|
9.373357888275
|
-14-15-dihete
|
(±)14,15-Dihydroxy-Eicosa-5,8,11,17-Tetraenoic Acid
|
epoxygenases metabolites EPA eicosapentaenoic acids epoxidations hydroxylations w-3 .omega.-3 fatty acids marine organisms incubated rats livers microsomes colitis homogenates cytochromes P450-catlyzed epoxidations w-6 .omega.-6 double bonds conversion vicinal diols epoxides hydrolases excreted excretion humans ingesting fish oils supplements 14,15-dihete |
9.373357888275
|
| 10004946 |
14,15-EE-5(Z)-E
Exclusive |
|
519038-92-7 |
≥98%
|
|
✓ |
2007-01-15
|
34.172044198895
|
14-15-ee-5-z-e
|
14,15-Epoxyeicosa-5(Z)-enoic Acid
|
14,15-EpETrE 14,15-EETs antagonists hypertension vasodilation vasodilator vasoconstriction vasoconstrictor EDHT endothelium-derived hyperpolarizing factor U46619 bovine arteries endocrinology EEZE |
34.172044198895
|
| 10010486 |
14,15-EE-8(Z)-E
Exclusive |
|
519038-93-8 |
≥98%
|
|
✓ |
2008-11-03
|
13.297796193983
|
14-15-ee-8-z-e
|
14,15-Epoxyeicosa-8(Z)-enoic Acid
|
14,15-EETs 14,15-EpETrEs vasodilation vascular disease hypertension EEZE |
13.297796193983
|
| 50651 |
(±)14(15)-EET
|
|
- |
≥98%
|
|
|
|
46.859453652547
|
-14-15-eet
|
(±)14(15)-EpETrE
|
epoxides epoxygenases 14,15-EETs cytochrome P450 (+/-)14,15-EpETrEs (+/-)14(15)-EpETrEs |
46.859453652547
|
| 10006410 |
(±)14(15)-EET-d11
|
|
- |
≥99% deuterated forms (d1-d11)
|
|
|
2007-07-22
|
55.203977900552
|
-14-15-eet-d11
|
(±)14(15)-EpETrE-d11
|
epoxides epoxygenases cytochrome P450 (+/-)14(15)-EpETrEs (+/-)5,6-EpETrEs fatty acids deuterated deuterium CYP450 mass spectrometry MS 14,15-EETs biosynthesized liver microsomes pregnancy hypertension |
55.203977900552
|
| 10007263 |
(±)14(15)-EET Lipid Maps MS Standard
|
|
- |
≥98%
|
|
|
2009-02-11
|
11.008895027623
|
-14-15-eet-lipid-maps-ms-standard
|
(±)14(15)-EpETrE
|
epoxides epoxygenases 14,15-EETs cytochrome P450 (+/-)14,15-EpETrEs (+/-)14(15)-EpETrEs MS mass spectrometry standards |
11.008895027623
|
| 50650 |
(±)14(15)-EET methyl ester
|
|
- |
≥98%
|
|
|
|
13.980759668508
|
-14-15-eet-methyl-ester
|
(±)14(15)-EpETrE methyl ester
|
epoxides epoxygenases 14,15-EETs (+/-)14,15-EpETrEs (+/-)14(15)-EpETrEs esters |
13.980759668508
|
| 10173 |
14(15)-EpETE
|
|
131339-24-7 |
≥90%
|
|
|
2004-01-14
|
23.069585635359
|
14-15-epete
|
14,15-epoxy Eicosatetraenoic Acid; 14,15 EEQ
|
epoxides epoxygenases cytochrome P450 (±)14,15-EpETEs (+/-)14,15-EpETEs fatty acids (+/-)14(15)EpETrEs 14(15)EETs eicosatrienoic 14,15-EEQ 14,15EEQ |
23.069585635359
|
| 33550 |
(±)14-HDoHE
|
|
87042-40-8 |
≥98%
|
|
|
|
12.088759876324
|
-14-hdohe
|
14-hydroxy Docosahexaenoic Acid
|
racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)14-HDoHEs (+/-)HDoHEs neurochemistry |
12.088759876324
|
| 37700 |
(±)15-HEDE
|
|
77159-57-0 |
≥98%
|
|
|
|
0.337679558011
|
-15-hede
|
|
hydroxy fatty acids autoxidation racemic (+/-)15-HEDEs (+/-)-HEDEs (+/-)HEDEs |
0.337679558011
|
| 32700 |
(±)15-HEPE
|
|
88852-33-9 |
≥98%
|
|
|
|
9.652007366483
|
-15-hepe
|
|
racemic hydroxy acids EPA autoxidation (+/-)15-HEPEs eicosapentaenoic (+/-)-HEPEs fatty (+/-)HEPEs |
9.652007366483
|
| 34700 |
(±)15-HETE
|
|
73836-87-0 |
≥98%
|
|
|
|
26.252209944751
|
-15-hete
|
|
racemic hydroxy acids autoxidation (+/-)15-HETEs fatty (+/-)-HETEs 15HETE |
26.252209944751
|
| 37730 |
15-OxoEDE
|
|
105835-44-7 |
>95%
|
|
|
|
7.393268876611
|
15-oxoede
|
15-KEDE
|
15-KEDEs 15-OxoEDEs fatty acids keto oxidation oxo-acids 15-oxo-EDEs |
7.393268876611
|
| 34730 |
15-OxoETE
|
|
81416-72-0 |
>98%
|
|
|
|
13.668287292818
|
15-oxoete
|
15-KETE
|
15-KETEs metabolites 15-LOs oxo-acids 15-lipoxygenases 15-oxoETEs 15-oxo-ETEs oxidation |
13.668287292818
|
| 37710 |
15(R)-HEDE
Exclusive |
|
- |
≥98%
|
|
✓ |
|
0.090883977900
|
15-r-hede
|
|
hydroxy fatty acids 15R-HEDEs 15-HEDEs 15(R)HEDEs eicosadienoic 15(R)-HEDEs |
0.090883977900
|
| 34710 |
15(R)-HETE
|
|
83603-31-0 |
≥98%
|
|
|
|
16.987182320442
|
15-r-hete
|
|
hydroxy fatty acids COX-2 cyclooxygenases PGHS2 PGHS-2 prostaglandin synthases 15-HETEs 15R-HETEs COX2 15(R)HETEs 15(R)-HETEs 15HETEs |
16.987182320442
|
| 37720 |
15(S)-HEDE
|
|
92693-04-4 |
≥98%
|
|
|
|
0.216500920810
|
15-s-hede
|
|
hydroxy fatty acids 15S-HEDEs 15-HEDEs 15(S)HEDEs 15(S)-HEDEs |
0.216500920810
|
| 32710 |
15(S)-HEPE
|
|
86282-92-0 |
≥98%
|
|
|
|
11.469524861879
|
15-s-hepe
|
|
hydroxy fatty acids EPA 15-LOs 15-lipoxygenases 15-HEPEs 15S-HEPEs 15(S)HEPEs eicosapentaenoic 15-HEPEs |
11.469524861879
|
| 34720 |
15(S)-HETE
|
|
54845-95-3 |
≥98%
|
|
|
|
33.067837411207
|
15-s-hete
|
|
soybean 15-LOs asthma airway 15-lipoxygenases monohydroxy fatty acids 15S-HETES 15-HETES arachidonic 15(S)-HETEs 15(S)HETEs potato polyunsaturated 15HETEs |
33.067837411207
|
| 34722 |
15(S)-HETE-biotin
|
|
- |
≥98% (may contain trace amounts of free biotin)
|
|
|
|
11.570690607734
|
15-s-hete-biotin
|
|
hydroxy fatty acids binding proteins receptors detection 15S-HETE-biotin 15(S)HETE-biotin 15S-HETES 15(S)-HETES 15(S)HETEs 15-HETEs 15HETEs |
11.570690607734
|
| 334720 |
15(S)-HETE-d8
|
|
84807-87-4 |
≥99% deuterated product
|
|
|
|
39.003388581951
|
15-s-hete-d8
|
|
GC/MS deuterium isotopes 15-HETE-d8 standards 15S-HETE-d8 15(S)HETE-d8 deuterated GC-MS LC/MS LC-MS 15-HETEs 15(S)-HETEs 15S-HETEs 15(S)HETEs hydroxy fatty acids mass spectrometry 15HETE |
39.003388581951
|
| 534721 |
15(S)-HETE EIA Kit
|
|
- |
|
|
|
|
73.417918968692
|
15-s-hete-eia-kit
|
15(S)-HETE ELISA Kit
|
solid plates 15(S)-HETEs 15S-HETEs measures kits eias enzyme immunoassays ELISAs 15(S)HETEs 15HETEs assays |
73.417918968692
|
| 10007251 |
15(S)-HETE Lipid Maps MS Standard
|
|
54845-95-3 |
≥98%
|
|
|
2009-02-17
|
17.652116447088
|
15-s-hete-lipid-maps-ms-standard
|
|
soybean 15-LOs asthma airway 15-lipoxygenases monohydroxy fatty acids 15S-HETES 15-HETES arachidonic 15(S)-HETEs 15(S)HETEs potato polyunsaturated MS mass spectrometry standards 15HETE |
17.652116447088
|
| 36720 |
15(S)-HETrE
|
|
92693-02-2 |
≥98%
|
|
|
|
39.608259668508
|
15-s-hetre
|
|
DGLA 15-LOs metabolites 15-lipoxygenases 15-HETrEs hydroxy fatty acids 15(S)-HETrEs 15-HETrEs 15(S)HETrEs |
39.608259668508
|
| 47720 |
15(S)-HpEDE
|
|
145375-41-3 |
≥98%
|
|
|
|
5.519972375690
|
15-s-hpede
|
|
eicosadienoic acids hydroperoxides 15S-HpEDEs 15-HpEDEs hydroperoxy fatty acids 15(S)-HpEDEs |
5.519972375690
|
| 42710 |
15(S)-HpEPE
|
|
125992-60-1 |
≥98%
|
|
|
|
3.995340699815
|
15-s-hpepe
|
|
hydroperoxides EPA 15-HpEPEs 15S-HpEPEs 15-LOs 15(S)-HpEPEs 15(S)HpEPEs 15-lipoxygenases hydroperoxy eicosapentaenoic fatty acids |
3.995340699815
|
| 44720 |
15(S)-HpETE
|
|
70981-96-3 |
≥98%
|
|
|
|
18.064521178636
|
15-s-hpete
|
|
15-LOs 15-HpETEs 15S-HpETEs hydroperoxides 15(S)-HpETEs 15(S)HPETEs 15-lipoxygenases monohydroperoxy fatty arachidonic acids polyunsaturated |
18.064521178636
|
| 10007259 |
15(S)-HpETE Lipid Maps MS Standard
|
|
70981-96-3 |
>98%
|
|
|
2009-02-10
|
10.265856353591
|
15-s-hpete-lipid-maps-ms-standard
|
|
15-LOs 15-HpETEs 15S-HpETEs hydroperoxides 15(S)-HpETEs 15(S)HPETEs 15-lipoxygenases monohydroperoxy fatty arachidonic acids polyunsaturated MS mass spectrometry standards |
10.265856353591
|
| 10174 |
16(17)-EpDPE
|
|
- |
≥90%
|
|
|
2004-01-14
|
24.917596685082
|
16-17-epdpe
|
16,17-epoxy Docosapentaenoic Acid; 16,17 EDP
|
epoxides epoxygenases cytochrome P450 (±)16,17-EpDPEs (+/-)16,17-EpDPEs fatty acids (+/-)16(17)EpDPEs 16(17)EETs eicosatrienoic neurochemistry 16,17-EDP 16,17EDP |
24.917596685082
|
| 33600 |
(±)16-HDoHE
|
|
90780-51-1 |
≥98%
|
|
|
|
10.762974217311
|
-16-hdohe
|
16-hydroxy Docosahexaenoic Acid
|
racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)16-HDoHEs (+/-)HDoHEs neurochemistry |
10.762974217311
|
| 10010635 |
(±)16-HETE
|
|
128914-46-5 |
≥98%
|
|
|
2008-06-09
|
24.688839779005
|
-16-hete
|
|
CYP450 eicosanoid metabolism kidneys ATPase ion transport vasodilation renal hypertension |
24.688839779005
|
| 10006999 |
(±)17,18-DiHETE
Exclusive |
|
- |
≥98%
|
|
✓ |
2005-07-13
|
6.350418310971
|
-17-18-dihete
|
(±)17,18-dihydroxy-eicosa-5,8,11,14-Tetraenoic Acid
|
EPAs eicosapentaenoic acids epoxidations hydroxylations epoxygenases metabolites w-3 .omega.-3 fatty marine organisms metabolites produced incubated rat tissues homogenates cynomolgus monkey seminal vesicles cytochrome P450-catalyzed double bond conversion vicinal diols epoxides hydrolases metabolized Gaeumannomyces graminis 116477-53-3 |
6.350418310971
|
| 50861 |
17(18)-EpETE
|
|
- |
≥90%
|
|
|
2004-01-14
|
24.449295580110
|
17-18-epete
|
17,18-epoxy Eicosatetraenoic Acid; 17,18 EEQ
|
epoxides epoxygenases cytochromes P450 (±)17,18-EpETEs (+/-)17,18-EpETEs fatty acids (+/-)17(18)EpETrEs 17(18) CYP450 CYP-450 epoxidation docosahexaenoic acids EETs eicosatrienoic EPA DHA 17,18-EEQ 17,18EEQ |
24.449295580110
|
| 33650 |
(±)17-HDoHE
|
|
90780-52-2 |
≥98%
|
|
|
|
13.732331066723
|
-17-hdohe
|
17-hydroxy Docosahexaenoic Acid
|
racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)17-HDoHEs (+/-)HDoHEs neurochemistry |
13.732331066723
|
| 10005099 |
17(R)-HDoHE
Exclusive |
|
155976-53-7 |
≥98%
|
|
✓ |
2005-01-05
|
24.270205209155
|
17-r-hdohe
|
17(R)-hydroxy Docosahexaenoic Acid
|
resolvins 17-HDHA docosahexaenoic acid COX-2 .omega.-3 w-3 aspirin hydroxylated metabolites oxygenation aspirin-inhibited cyclooxygenase-2 polyhydroxylated TNFa TNF.alpha. IL-1b IL-1.beta. glioma cells COX2 PGHS2 PGHS-2 prostaglandin synthases neurochemistry |
24.270205209155
|
| 10009799 |
17(S)-HDoHE
|
|
- |
≥98%
|
|
|
2007-03-12
|
10.232854511970
|
17-s-hdohe
|
17(S)-hydroxy Docosahexaenoic Acid
|
resolvins 17-HDHA docosahexaenoic acid COX-2 .omega.-3 w-3 aspirin hydroxylated metabolites oxygenation aspirin-inhibited cyclooxygenase-2 polyhydroxylated TNFa TNF.alpha. IL-1b IL-1.beta. glioma cells COX2 PGHS2 PGHS-2 prostaglandin synthases neurochemistry 17(s)-hdohe |
10.232854511970
|
| 13185 |
17(S)-HpDoHE
|
|
- |
≥98%
|
|
|
2009-07-02
|
5.747817679557
|
17-s-hpdohe
|
17(S)-hydroperoxy Docosahexaenoic Acid
|
inhibitor inhibitors inhibits DHA 17S-HpDOHE 17SHpDoHE mono-oxygenation 17(S)-resolvins 17S-resolvins TNFs TNF-α TNFα 17(s)-hpdohe 17s-hdohe
|
5.747817679557
|
| 32840 |
(±)18-HEPE
|
|
141110-17-0 |
≥97%
|
|
|
|
17.348768745067
|
-18-hepe
|
|
racemic hydroxy acids EPA autoxidation (+/-)18-HEPEs eicosapentanoic fatty (+/-)-HEPEs (+/-)HEPEs |
17.348768745067
|
| 10007001 |
(±)19,20-DiHDPA
|
|
- |
≥98%
|
|
|
2005-09-15
|
34.382880820837
|
-19-20-dihdpa
|
(±)19,20-DiHDoPE
|
epoxygenases metabolites DHA docosahexaenoic acids fatty w-3 omega-3 .omega.-3 neural tissues retina brain incubated incubation NADPH-supplemented nicotinamide adenine dinucleotide phosphates rat livers microsomes metabolized metabolizing monkey seminal vesicles cytochromes P450-catalyzed CYP450 epoxidation double bond vicinal diols epoxide hydrolases hydroxylation 138705-17-6 |
34.382880820837
|
| 10175 |
19(20)-EpDPE
|
|
- |
≥98%
|
|
|
2004-01-14
|
34.789093922651
|
19-20-epdpe
|
19,20-epoxy Docosapentaenoic Acid; 19,20 EDP
|
metabolites epoxides epoxygenases cytochrome P450 (±)19,20-EpDPEs (+/-)19,20-EpDPEs fatty acids (+/-)19(20)EpDPEs 19(20)EETs eicosatetraenoic 19,20-EETs neurochemistry 19,20-EDP 19,20EDP |
34.789093922651
|
| 10007767 |
19(R)-HETE
|
|
115461-39-7 |
≥98%
|
|
|
2008-05-27
|
7.770165745856
|
19-r-hete
|
|
hypertension arterioles CYP450 kidneys angiotensin II vasodilator vasoconstricition 20-HETE 19HETE 19-HETE renal 19 HETE |
7.770165745856
|
| 10007766 |
19(S)-HETE
Exclusive |
|
115461-40-0 |
≥98%
|
|
✓ |
2010-04-06
|
27.706500920810
|
19-s-hete
|
|
cytochromes P450 CYP450 metabolites arachidonic acids kidneys angiotensin II CYP2E1 vasodilators renal preglomerular vessels ATPase hypertension arterioles vasoconstriction Acids Hydroxyeicosatetraenoic
Hydroxyeicosatetraenoic Acids
HETE |
27.706500920810
|
| 33750 |
(±)20-HDoHE
|
|
90906-41-5 |
≥98%
|
|
|
|
12.469972375690
|
-20-hdohe
|
20-hydroxy Docosahexaenoic Acid
|
racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)20-HDoHEs (+/-)HDoHEs neurochemistry |
12.469972375690
|
| 90030 |
20-HETE
|
|
79551-86-3 |
≥98%
|
|
|
|
66.338568558513
|
20-hete
|
20-hydroxy Arachidonic Acid
|
hydroxy fatty acids omega-oxidation .omega.-oxidation w-oxidation cytochrome P450 CYP450 arachidonic HETEs metabolites P-450 vasoconstrictors vasoconstriction |
66.338568558513
|
| 390030 |
20-HETE-d6
|
|
- |
≥99% deuterated product
|
|
|
|
77.450497237569
|
20-hete-d6
|
20-hydroxy Arachidonic Acid-d6
|
CYP450 vasocontriction standards vasoconstrictors GC-MS GC/MS LC-MS LC/MS cytochrome chromatography mass spectroscopy deuterium deuterateds |
77.450497237569
|
| 10007269 |
20-HETE Lipid Maps MS Standard
|
|
79551-86-3 |
≥98%
|
|
|
2009-02-18
|
22.125657458563
|
20-hete-lipid-maps-ms-standard
|
20-hydroxy Arachidonic Acid
|
hydroxy fatty acids omega-oxidation .omega.-oxidation w-oxidation cytochrome P450 CYP450 arachidonic HETEs metabolites P-450 vasoconstrictors vasoconstriction MS mass spectrometry standards |
22.125657458563
|
| 90314 |
4(5)-EpDPE methyl ester
|
|
121818-29-9 |
≥98%
|
|
|
|
24.003793738489
|
4-5-epdpe-methyl-ester
|
4,5-epoxy Docosapentaenoic Acid methyl ester
|
cytochrome P450 metabolites epoxide epoxygenase neurochemistry |
24.003793738489
|
| 33200 |
(±)4-HDoHE
|
|
90906-40-4 |
≥98%
|
|
|
|
12.785344703339
|
-4-hdohe
|
4-hydroxy Docosahexaenoic Acid
|
racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)4-HDoHEs (+/-)HDoHEs neurochemistry |
12.785344703339
|
| 10004413 |
4-hydroperoxy 2-Nonenal
Exclusive |
|
7439-43-2 |
>95%
|
|
✓ |
2005-05-25
|
44.355071823204
|
4-hydroperoxy-2-nonenal
|
4-HpNE
|
free radicals peroxidation lipids oxidized w-6 .omega.-6 omega-6 PUFAs polyunsaturated fatty acids linoleics arachidonics oxidative stress cytotoxicity growth inhibiting activity genotoxicity chemotactic 4-HNE 4-hydroxy nonenals 4-OH-nonenal 4-hydroxynonenal hydroperoxides injury |
44.355071823204
|
| 32060 |
4-hydroxy Hexenal
|
|
160708-91-8 |
≥98%
|
|
|
|
186.314364640884
|
4-hydroxy-hexenal
|
4-HHE
|
ROS alkenal aldehydes radicals peroxidation lipids autoxidation reactive oxygen species free 4-OH-hexenal |
186.314364640884
|
| 32100 |
4-hydroxy Nonenal
|
|
75899-68-2 |
>98%
|
|
|
|
179.259321231255
|
4-hydroxy-nonenal
|
4-HNE
|
ROS alkenals aldehydes free radicals peroxidation lipid autoxidation reactive oxygen species 4-OH-nonenal 4-hydroxynonenal |
179.259321231255
|
| 13265 |
4-hydroxy Nonenal Alkyne
Exclusive |
|
1011268-23-7 |
≥98%
|
|
✓ |
2010-06-16
|
121.635972989564
|
4-hydroxy-nonenal-alkyne
|
Click Tag™ 4-HNE alkyne
|
lipids peroxidation inflammation neurodegeneration atherosclerosis diabetes cancers click chemistry Click Tag™ 4-HNEs alkynes IT |
121.635972989564
|
| 332101 |
4-hydroxy Nonenal-d3
|
|
- |
≥99% deuterated product
|
|
|
2004-01-28
|
48.072991318074
|
4-hydroxy-nonenal-d3
|
4-HNE-d3
|
ROS alkenals aldehydes free radicals peroxidation lipid autoxidation reactive oxygen species 4-OH-nonenal 4-hydroxynonenal deuterium deuterateds |
48.072991318074
|
| 32110 |
4-hydroxy Nonenal Mercapturic Acid
Exclusive |
|
146764-24-1 |
>98%
|
|
✓ |
|
0.669889502762
|
4-hydroxy-nonenal-mercapturic-acid
|
|
4-HNE 4HNE b-cleavage .beta.-cleavage beta-cleavage urine enterohepatic circulation conjugates acids 4-hydroxynonenal 4-OH-nonenal |
0.669889502762
|
| 9000348 |
4-hydroxy Nonenal Mercapturic Acid-d3
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2008-12-03
|
25.926250986582
|
4-hydroxy-nonenal-mercapturic-acid-d3
|
|
4-HNE 4HNE b-cleavage .beta.-cleavage beta-cleavage urine enterohepatic circulation conjugates acids 4-hydroxynonenal 4-OH-nonenal deuterium deuterateds |
25.926250986582
|
| 10185 |
4-oxo-2-Nonenal
Exclusive |
|
103560-62-9 |
>98%
|
|
✓ |
2004-01-21
|
65.065966850828
|
4-oxo-2-nonenal
|
4-ONE
|
ROS Alkenals aldehydes free radicals peroxidation lipid autoxidation reactive oxygen species |
65.065966850828
|
| 10004174 |
4-oxo 2-Nonenal-d3
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2004-03-10
|
33.350589318600
|
4-oxo-2-nonenal-d3
|
4-ONE-d3
|
ROS Alkenals aldehydes free radicals peroxidation lipid autoxidation reactive oxygen species 4-OH-2-nonenal-d3 4-hydroxy2nonenald3 internal standards mass spectrometry GC/MS LC/MS gc-ms ic-ms deuterium deuterateds |
33.350589318600
|
| 51211 |
(±)5,6-DHET
|
|
213382-49-1 |
≥98%
|
|
|
|
12.326657458563
|
-5-6-dhet
|
(±)5,6-DiHETrE
|
epoxides epoxygenases DHT hydrolases (+/-)5,6-DiHETrEs |
12.326657458563
|
| 51212 |
(±)5,6-DHET lactone
Exclusive |
|
213126-92-2 |
>98%
|
|
✓ |
|
8.352596685083
|
-5-6-dhet-lactone
|
(±)5,6-DiHETrE lactone
|
epoxides epoxygenases DHT lactones hydrolases (+/-)5,6-DiHETrEs DHETs |
8.352596685083
|
| 10007264 |
(±)5,6-DHET Lipid Maps MS Standard
|
|
- |
≥98%
|
|
|
2009-02-14
|
7.868591160221
|
-5-6-dhet-lipid-maps-ms-standard
|
(±)5,6-DiHETrE
|
epoxides epoxygenases DHT hydrolases (+/-)5,6-DiHETrEs MS mass spectrometry standards |
7.868591160221
|
| 10467 |
5,6-DiHETE
Exclusive |
|
845673-97-4 |
≥97%
|
|
✓ |
2011-06-13
|
5.373638516179
|
5-6-dihete
|
|
eicosapentaenoic acids EPAs cytochromes P450 P-450 metabolites polyunsaturated fatty metabolites ω-3 omega epoxidation 5(6)-DiHETE DiHETEs epoxide hydrolases CYP450 |
5.373638516179
|
| 50211 |
(±)5(6)-EET
|
|
- |
≥98%
|
|
|
|
12.565074980268
|
-5-6-eet
|
(±)5(6)-EpETrE
|
epoxides epoxygenases cytochrome P450 (+/-)5(6)-EpETrEs (+/-)5,6-EpETrEs 5,6-EETs fatty acids |
12.565074980268
|
| 10009984 |
(±)5(6)-EET-d11
|
|
- |
≥99% deuterated forms (d1-d11)
|
|
|
2007-06-06
|
12.800220994475
|
-5-6-eet-d11
|
(±)5(6)-EpETrE-d11
|
epoxides epoxygenases cytochrome P450 (+/-)5(6)-EpETrEs (+/-)5,6-EpETrEs 5,6-EETs fatty acids deuterated deuterium |
12.800220994475
|
| 10007260 |
(±)5(6)-EET Lipid Maps MS Standard
|
|
- |
>98%
|
|
|
2009-02-05
|
6.122527624309
|
-5-6-eet-lipid-maps-ms-standard
|
(±)5(6)-EpETrE
|
epoxides epoxygenases cytochrome P450 (+/-)5(6)-EpETrEs (+/-)5,6-EpETrEs 5,6-EETs fatty acids MS mass spectrometry standards |
6.122527624309
|
| 50210 |
(±)5(6)-EET methyl ester
|
|
- |
≥98%
|
|
|
|
5.334544198895
|
-5-6-eet-methyl-ester
|
(±)5(6)-EpETrE methyl ester
|
epoxides epoxygenases 5,6-EETs cytochrome P450 (+/-)5(6)-EpETrEs (+/-)5,6-EpETrEs fatty acids esters |
5.334544198895
|
| 90114 |
5(6)-EpETE methyl ester
|
|
127716-49-8 |
≥98%
|
|
|
|
6.644607734806
|
5-6-epete-methyl-ester
|
5,6-epoxy Eicosatetraenoic Acid methyl ester
|
EPA metabolites epoxygenase |
6.644607734806
|
| 32200 |
(±)5-HEPE
|
|
83952-40-3 |
≥97%
|
|
|
|
17.778983425414
|
-5-hepe
|
|
racemic hydroxy acids fatty EPA autoxidation (+/-)5-HEPEs eicosapentanoic (+/-)-HEPEs (+/-)HEPEs |
17.778983425414
|
| 34210 |
(±)5-HETE
|
|
73307-52-5 |
≥98%
|
|
|
|
9.457430939226
|
-5-hete
|
|
racemic hydroxy acids autoxidation (+/-)5-HETEs fatty arachidonic AA (+/-)-HETEs (+/-)HETEs |
9.457430939226
|
| 34215 |
(±)5-HETE lactone
|
|
73279-37-5 |
≥98%
|
|
|
|
7.763629834254
|
-5-hete-lactone
|
|
racemic hydroxy acids lactones autoxidation (+/-)5-HETEs fatty (+/-)-HETEs (+/-)HETEs inhibitors inhibits 5-LOs 5-lipoxygenases |
7.763629834254
|
| 34220 |
(±)5-HETE methyl ester
|
|
73279-38-6 |
≥98%
|
|
|
|
7.944198895028
|
-5-hete-methyl-ester
|
|
racemic hydroxy acids autoxidation (+/-)5-HETEs fatty (+/-)-HETEs esters AA (+/-)HETEs arachidonic (+/-)5-HETE-OMe |
7.944198895028
|
| 34250 |
5-OxoETE
|
|
106154-18-1 |
>95%
|
|
|
|
17.887095501184
|
5-oxoete
|
5-KETE
|
5-HETEs oxo-acids 5-LOs metabolites chemotactic fatty 5-lipoxygenases 5-oxo-etes polyunsaturated PUFAs |
17.887095501184
|
| 334250 |
5-OxoETE-d7
|
|
- |
≥99% deuterated product
|
|
|
|
22.323535911603
|
5-oxoete-d7
|
5-KETE-d7
|
GC/MS deuterium isotopes 5-KETEs oxo-acids 5oxoetes 5ketes 5-oxo-ete-d7 standards fatty LC/MS GC-MS LC-MS mass spectrometry deuterated 5-oxoETEs |
22.323535911603
|
| 10007244 |
5-OxoETE Lipid Maps MS Standard
|
|
106154-18-1 |
>95%
|
|
|
2009-01-05
|
9.715497237569
|
5-oxoete-lipid-maps-ms-standard
|
5-KETE
|
5-HETEs oxo-acids 5-LOs metabolites chemotactic fatty 5-lipoxygenases 5-oxo-etes polyunsaturated PUFAs MS mass spectrometry standards |
9.715497237569
|
| 34225 |
5(R)-HETE
|
|
61641-47-2 |
≥98%
|
|
|
|
8.023149171270
|
5-r-hete
|
|
arachidonic 5-lipoxygenases 5R-HETEs 5-HETEs hydroxy fatty acids 5(R)-HETEs 5(R)HETEs 5-LOs |
8.023149171270
|
| 90420 |
5(S),14(R)-Lipoxin B4
|
|
98049-69-5 |
>95%
|
|
|
2008-11-17
|
45.002811540823
|
5-s-14-r-lipoxin-b4
|
5(S),14(R)-LXB4
|
LXB4 trihydroxy fatty acids leukocyte activation LXA4 inflammation lipoxins inhibits inhibition inhibitiors |
45.002811540823
|
| 35280 |
5(S),15(S)-DiHETE
|
|
82200-87-1 |
≥98%
|
|
|
|
4.581368442394
|
5-s-15-s-dihete
|
|
15-LOs dihydroxy fatty acids 15-lipoxygenases 5S,15S-DiHETEs 5,15-DiHETEs 5(S),15(S)-DiHETEs |
4.581368442394
|
| 10007255 |
5(S),15(S)-DiHETE Lipid Maps MS Standard
|
|
82200-87-1 |
≥98%
|
|
|
2009-02-18
|
6.128360957643
|
5-s-15-s-dihete-lipid-maps-ms-standard
|
|
15-LOs dihydroxy fatty acids 15-lipoxygenases 5S,15S-DiHETEs 5,15-DiHETEs 5(S),15(S)-DiHETEs MS mass spectrometry standards |
6.128360957643
|
| 10009628 |
5(S),6(R)-11-trans DiHETE
|
|
- |
≥95%
|
|
|
2007-08-06
|
12.580079803560
|
5-s-6-r-11-trans-dihete
|
|
5(S),6(S)-diHETE LTA4 LTB4 6-trans-12-epi epoxides hydrolase kidneys rats homogenates |
12.580079803560
|
| 90415 |
5(S),6(R),15(R)-Lipoxin A4
|
|
171030-11-8 |
≥95%
|
|
|
2008-11-17
|
86.651298342541
|
5-s-6-r-15-r-lipoxin-a4
|
5(S),6(R),15(R)-LXA4; AT-Lipoxin A4; 15-epi Lipoxin A4
|
inflammations lipoxins aspirins ASA neutrophils inflammatory aspirins triggered |
86.651298342541
|
| 35200 |
5(S),6(R)-DiHETE
|
|
82948-88-7 |
≥98%
|
|
|
|
7.478729281767
|
5-s-6-r-dihete
|
|
LTA4 hydrolysis DHT 5S,6R-DiHETEs 5(S),6(R)-DiHETEs 5,6-DiHETEs |
7.478729281767
|
| 10007252 |
5(S),6(R)-DiHETE Lipid Maps MS Standard
|
|
82948-88-7 |
>99%
|
|
|
2009-02-17
|
4.631786372007
|
5-s-6-r-dihete-lipid-maps-ms-standard
|
|
LTA4 hydrolysis DHT 5S,6R-DiHETEs 5(S),6(R)-DiHETEs 5,6-DiHETEs MS mass spectrometry standards |
4.631786372007
|
| 90410 |
5(S),6(R)-Lipoxin A4
|
|
89663-86-5 |
≥95%
|
|
|
|
136.045439864003
|
5-s-6-r-lipoxin-a4
|
5(S),6(R)-LXA4; 5(S),6(R),15(S)-TriHETE
|
LXA4 lipoxins trihydroxy fatty acids leukocytes activation |
136.045439864003
|
| 10007271 |
5(S),6(R)-Lipoxin A4 Lipid Maps MS Standard
|
|
89663-86-5 |
≥95%
|
|
|
2009-02-18
|
43.257486187845
|
5-s-6-r-lipoxin-a4-lipid-maps-ms-standard
|
5(S),6(R),15(S)-TriHETE; 5(S),6(R)-LXA4
|
LXA4 lipoxins trihydroxy fatty acids leukocytes activation MS mass spectrometry standards |
43.257486187845
|
| 10033 |
5(S),6(R)-Lipoxin A4 methyl ester
|
|
97643-35-1 |
>95%
|
|
|
2004-04-01
|
67.310176795580
|
5-s-6-r-lipoxin-a4-methyl-ester
|
5(S),6(R)-LXA4 methyl ester; 5(S),6(R),15(S)-TriHETE methyl ester
|
LXA4ME LXA4-ME lipoxins trihydroxy fatty acids leukocytes activation prodrugs syoerixude generation esters |
67.310176795580
|
| 35210 |
5(S),6(S)-DiHETE
|
|
82948-87-6 |
≥98%
|
|
|
|
7.166588397790
|
5-s-6-s-dihete
|
|
LTA4 hydrolysis DHT 5S,6S-DiHETEs 5(S),6(S)-DiHETEs 5,6-DiHETEs |
7.166588397790
|
| 10007253 |
5(S),6(S)-DiHETE Lipid Maps MS Standard
|
|
82948-87-6 |
≥98%
|
|
|
2009-02-17
|
7.253057090239
|
5-s-6-s-dihete-lipid-maps-ms-standard
|
|
LTA4 hydrolysis DHT 5S,6S-DiHETEs 5(S),6(S)-DiHETEs 5,6-DiHETEs MS mass spectrometry standards |
7.253057090239
|
| 10049 |
5(S),6(S)-Lipoxin A4
|
|
- |
>95%
|
|
|
2004-06-29
|
115.163093922652
|
5-s-6-s-lipoxin-a4
|
5(S),6(S),15(S)-TriHETE; 5(S),6(S)-LXA4
|
LXA4 lipoxins trihydroxy fatty acids leukocytes activation 11-cis isomers |
115.163093922652
|
| 32210 |
5(S)-HEPE
|
|
92008-51-0 |
≥98%
|
|
|
|
20.917127071822
|
5-s-hepe
|
|
hydroxy acids EPA 5s-HEPEs 5(S)-HEPEs 5-HEPEs eicosapentanoic 5-lipoxygenases fatty 5(S)HEPEs 5-LOs |
20.917127071822
|
| 34230 |
5(S)-HETE
|
|
70608-72-9 |
≥98%
|
|
|
|
32.249221915285
|
5-s-hete
|
|
arachidonic 5-lipoxygenases 5-LOs hydroxy acids 5S-HETEs 5-HETEs 5(S)-HETEs 5(S)HETEs fatty |
32.249221915285
|
| 334230 |
5(S)-HETE-d8
|
|
330796-62-8 |
≥99% deuterated product
|
|
|
|
35.300469613259
|
5-s-hete-d8
|
|
GC/MS deuterium isotopes 5-HETEs 5S-HETEs standards hydroxy fatty acids LC/MS GC-MS LC-MS mass spectrometry 5-HETE-d8 5S-HETE-d8 5(S)-HETEs deuterated 5(S)HETES 5(S)HETE-d8 |
35.300469613259
|
| 10007276 |
5(S)-HETE-d8 Lipid Maps MS Standard
|
|
- |
≥99% deuterated product
|
|
|
2009-02-26
|
24.627306629834
|
5-s-hete-d8-lipid-maps-ms-standard
|
|
GC/MS deuterium isotopes 5-HETEs 5S-HETEs standards hydroxy fatty acids LC/MS GC-MS LC-MS mass spectrometry 5-HETE-d8 5S-HETE-d8 5(S)-HETEs deuterated 5(S)HETES 5(S)HETE-d8 |
24.627306629834
|
| 34240 |
5(S)-HETE lactone
|
|
127708-42-3 |
≥98%
|
|
|
|
9.053167587476
|
5-s-hete-lactone
|
|
5-LOs hydroxy acids lactones 5S-HETEs 5-HETEs fatty 5(S)-HETEs 5(S)HETEs 5-lipoxygenases inhibitors inhibits 5-LOs |
9.053167587476
|
| 10007243 |
5(S)-HETE Lipid Maps MS Standard
|
|
70608-72-9 |
>98%
|
|
|
2009-01-06
|
24.919889502762
|
5-s-hete-lipid-maps-ms-standard
|
|
arachidonic 5-lipoxygenases 5-LOs hydroxy acids 5S-HETEs 5-HETEs 5(S)-HETEs 5(S)HETEs fatty MS mass spectrometry standards |
24.919889502762
|
| 36230 |
5(S)-HETrE
|
|
- |
≥98%
|
|
|
|
13.472845303867
|
5-s-hetre
|
|
5-LOs Mead acids 5-lipoxygenases metabolites 5S-HETrEs 5(S)HETrEs 5-HETrEs hydroxy fatty acids 5(S)-HETrEs |
13.472845303867
|
| 42210 |
5(S)-HpEPE
|
|
- |
≥98%
|
|
|
|
3.898213627992
|
5-s-hpepe
|
|
EPA hydroperoxides 5-HpEPEs 5S-HpEPEs 5-LOs eicosapentaenoic fatty acids hydroperoxy 5-lipoxygenases 5(S)-HpEPEs 5(S)HpEPEs |
3.898213627992
|
| 44230 |
5(S)-HpETE
|
|
71774-08-8 |
≥98%
|
|
|
|
19.543186003683
|
5-s-hpete
|
|
5-LOs 5-HpETEs hydroperoxides 5S-HpETEs 5(S)HpETEs hydroperoxy 5-lipoxygenases 5(S)-HpETEs arachidonic fatty acids leukotrienes |
19.543186003683
|
| 10007257 |
5(S)-HpETE Lipid Maps MS Standard
|
|
71774-08-8 |
≥98%
|
|
|
2009-02-04
|
8.932044198895
|
5-s-hpete-lipid-maps-ms-standard
|
|
5-LOs 5-HpETEs hydroperoxides 5S-HpETEs 5(S)HpETEs hydroperoxy 5-lipoxygenases 5(S)-HpETEs arachidonic fatty acids leukotrienes MS mass spectrometry standards |
8.932044198895
|
| 33300 |
(±)7-HDoHE
|
|
90780-55-5 |
≥98%
|
|
|
|
12.675405156537
|
-7-hdohe
|
7-hydroxy Docosahexaenoic Acid
|
racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)7-HDoHEs (+/-)HDoHEs neurochemistry |
12.675405156537
|
| 10878 |
7(R)-Maresin 1
New |
|
1268720-28-0 |
≥95%
|
|
|
2012-02-01
|
204.905314917127
|
7-r-maresin-1
|
7(R)-MaR1
|
docosahexaenoic acids DHA macrophages zymosan inflammation phagocytosis fatty brain retina murine peritonitis FITC 7(R) maresin 1 mar 1 |
204.905314917127
|
| 10546 |
7(S),17(S)-dihydroxy-8(E),10(Z),13(Z),15(E),19(Z)-Docosapentaenoic Acid
Exclusive |
|
887752-13-8 |
≥98%
|
|
✓ |
2010-10-22
|
4.819226519337
|
7-s-17-s-dihydroxy-8-e-10-z-13-z-15-e-19-z-docosapentaenoic-acid
|
7(S),17(S)-hydroxy DPA
|
opxylipin docosanoid DPAs DHAs protectins D1 anti-inflammatory fatty acids |
4.819226519337
|
| 13161 |
7(S)-Maresin 1
Exclusive |
|
1268720-66-6 |
≥95%
|
|
✓ |
2010-08-19
|
88.116926167754
|
7-s-maresin-1
|
7(S)-MaR1
|
docosahexaenoic acids DHA macrophages zymosan A inflammation phagocytosis lipids zymosan-A peritoneum FITC-labeled FITC labeled mouse murine mice 7,14-dihydroxy 14S-hydroperoxy 887752-49-0 inflammation antiinflammatory anti-inflammation antiinflammation Docosahexaenoic Acid |
88.116926167754
|
| 51351 |
(±)8,9-DHET
|
|
192461-96-4 |
≥98%
|
|
|
|
11.931160220995
|
-8-9-dhet
|
(±)8,9-DiHETrE
|
epoxides epoxygenases DHT hydrolases (+/-)8,9-DiHETrEs |
11.931160220995
|
| 10007265 |
(±)8,9-DHET Lipid Maps MS Standard
|
|
- |
≥98%
|
|
|
2009-02-11
|
7.775953038674
|
-8-9-dhet-lipid-maps-ms-standard
|
(±)8,9-DiHETrE
|
epoxides epoxygenases DHT hydrolases (+/-)8,9-DiHETrEs MS mass spectrometry standards |
7.775953038674
|
| 18112 |
8,9-EE-14(Z)-E
Exclusive |
|
- |
≥95%
|
|
✓ |
2009-03-15
|
9.932679558011
|
8-9-ee-14-z-e
|
8,9-Epoxyeicosa-14(Z)-enoic Acid
|
14,15-EETs 14,15-EpETrEs vasodilation vascular disease hypertension EEZE |
9.932679558011
|
| 50351 |
(±)8(9)-EET
|
|
- |
≥98%
|
|
|
|
14.122342541436
|
-8-9-eet
|
(±)8(9)-EpETrE
|
epoxides epoxygenases cytochrome P450 (±)8,9-EpETrEs (+/-)8,9-EpETrEs fatty acids (+/-)8(9)EpETrEs 8(9)EETs eicosatrienoic 8,9-EETs |
14.122342541436
|
| 10007261 |
(±)8(9)-EET Lipid Maps MS Standard
|
|
- |
≥98%
|
|
|
2009-02-10
|
7.550187845303
|
-8-9-eet-lipid-maps-ms-standard
|
(±)8(9)-EpETrE
|
epoxides epoxygenases cytochrome P450 (±)8,9-EpETrEs (+/-)8,9-EpETrEs fatty acids (+/-)8(9)EpETrEs 8(9)EETs eicosatrienoic 8,9-EETs MS mass spectrometry standards |
7.550187845303
|
| 50350 |
(±)8(9)-EET methyl ester
|
|
- |
≥98%
|
|
|
|
7.567983425414
|
-8-9-eet-methyl-ester
|
(±)8(9)-EpETrE methyl ester
|
epoxides epoxygenases 8,9-EETs cytochrome P450 (+/-)8(9)-EpETrEs (+/-)8,9-EpETrEs esters fatty acids |
7.567983425414
|
| 10470 |
8(9)-EpETE
Exclusive |
|
851378-93-3 |
≥95%
|
|
✓ |
2011-01-10
|
2.071767955801
|
8-9-epete
|
8,9-EEQ; 8,9-epoxy Eicosatetraenoic Acid
|
eicosapentaenoic acids EPA epoxyeicosatetraenoic EpETEs EETeTr cytochromes P450 epoxygenases CYP450 (±)-8(9)-epoxy-8Z,11Z,14Z,17Z- eicosatetraenoic |
2.071767955801
|
| 33350 |
(±)8-HDoHE
|
|
90780-54-4 |
≥98%
|
|
|
|
10.762974217311
|
-8-hdohe
|
8-hydroxy Docosahexaenoic Acid
|
racemic autoxidation DHA hydroxy fatty acids docosahexaenoic (+/-)8-HDoHEs (+/-)HDoHEs neurochemistry |
10.762974217311
|
| 32340 |
(±)8-HEPE
|
|
- |
≥98%
|
|
|
|
7.026530968304
|
-8-hepe
|
|
racemic hydroxy acids EPA autoxidation (+/-)8-HEPEs eicosapentanoic (+/-)-HEPEs fatty (+/-)HEPEs |
7.026530968304
|
| 34340 |
(±)8-HETE
|
|
79495-84-4 |
≥98%
|
|
|
|
7.932123125493
|
-8-hete
|
|
racemic hydroxy acids autoxidation (+/-)8-HETEs (+/-)-HETEs (+/-)HETEs |
7.932123125493
|
| 34350 |
8(R)-HETE
|
|
105500-09-2 |
≥98%
|
|
|
|
7.190184162062
|
8-r-hete
|
|
8-LOs hydroxy acids 8-lipoxygenases coral gorgonian 8R-HETEs 8-HETEs fatty 8(R)-HETEs 8(R)HETEs |
7.190184162062
|
| 35370 |
8(S),15(S)-DiHETE
|
|
80234-65-7 |
≥98%
|
|
|
|
6.138674033149
|
8-s-15-s-dihete
|
|
8-LOs 15-LOs 8S,15S-DiHETEs 8-lipoxygenases 15-lipoxygenases 8,15-DiHETEs 8(S),15(S)-DiHETEs |
6.138674033149
|
| 32350 |
8(S)-HEPE
|
|
118492-81-2 |
≥98%
|
|
|
|
5.724033149171
|
8-s-hepe
|
|
hydroxy acids EPA fatty 8S-HEPEs 8(S)HEPEs 8-HEPEs eicosapentanoic 8-lipoxygenases 8(S)-HEPES 8-LOs |
5.724033149171
|
| 34360 |
8(S)-HETE
|
|
98462-03-4 |
≥98%
|
|
|
|
6.260475138122
|
8-s-hete
|
|
hydroxy acids 8S-HETEs 8-HETEs fatty 8(S)-HETEs 8(S)HETEs |
6.260475138122
|
| 10007245 |
8(S)-HETE Lipid Maps MS Standard
|
|
98462-03-4 |
>98%
|
|
|
2009-01-05
|
6.517049723757
|
8-s-hete-lipid-maps-ms-standard
|
|
hydroxy acids 8S-HETEs 8-HETEs fatty 8(S)-HETEs 8(S)HETEs MS mass spectrometry standards |
6.517049723757
|
| 36360 |
8(S)-HETrE
|
|
- |
≥98%
|
|
|
|
6.213996316758
|
8-s-hetre
|
|
DGLA 8-LOs metabolites 8S-HETrEs hydroxy fatty acids 8(S)-HETrEs 8-HETrEs 8(S)HETrEs 8-lipoxygenases dihomo-gamma-linoleic dihomo-g-linoleic dihomo-.gamma.-linoleic |
6.213996316758
|
| 53400 |
(±)9,10-DiHOME
|
|
263399-34-4 |
≥98%
|
|
|
|
7.355874769797
|
-9-10-dihome
|
Leukotoxin diol
|
epoxides epoxygenase leukotoxin cytochrome P450 (+/-)9(10)-DiHOMes (+/-)9,10-DiHOMes CYP450 |
7.355874769797
|
| 10009993 |
(±)9,10-DiHOME-d4
|
|
- |
≥99% deuterated forms (d1-d4)
|
|
|
2007-06-01
|
4.717458563536
|
-9-10-dihome-d4
|
Leukotoxin diol-d4
|
epoxides epoxygenase leukotoxin cytochrome P450 (+/-)9(10)-DiHOMes (+/-)9,10-DiHOMes CYP450 deuterated duteriums |
4.717458563536
|
| 52400 |
(±)9(10)-EpOME
|
|
- |
≥98%
|
|
|
|
5.713991712707
|
-9-10-epome
|
Leukotoxin; 9,10-EODE
|
epoxides epoxygenasse leukotoxin cytochrome P450 (+/-)9(10)-EpOMEs (+/-)9,10-EpOMEs epoxy fatty acids (±)9(10)-epome |
5.713991712707
|
| 10009995 |
(±)9(10)-EpOME-d4
|
|
- |
≥99% deuterated forms (d1-d4)
|
|
|
2007-06-01
|
2.314217311234
|
-9-10-epome-d4
|
Leukotoxin-d4; 9,10-EODE-d4
|
epoxides epoxygenasse leukotoxin cytochrome P450 (+/-)9(10)-EpOMEs (+/-)9,10-EpOMEs epoxy fatty acids deuterated deuterium |
2.314217311234
|
| 32400 |
(±)9-HEPE
|
|
- |
≥98%
|
|
|
|
5.703701657459
|
-9-hepe
|
|
racemic hydroxy acids EPA autoxidation (+/-)9-HEPEs eicosapentanoic fatty (+/-)-HEPEs (+/-)HEPEs |
5.703701657459
|
| 34400 |
(±)9-HETE
|
|
79495-85-5 |
≥98%
|
|
|
|
12.025138121547
|
-9-hete
|
|
racemic hydroxy acids autoxidation (+/-)9-HETEs fatty (+/-)-HETEs (+/-)HETEs |
12.025138121547
|
| 38400 |
(±)9-HODE
|
|
98524-19-7 |
≥98%
|
|
|
|
48.052707182320
|
-9-hode
|
|
racemic hydroxy fatty acids autoxidation (+/-)9-HODEs (+/-)HODEs (+/-)-HODEs oxidized |
48.052707182320
|
| 38401 |
(±)9-HODE cholesteryl ester
|
|
33783-76-5 |
≥98%
|
|
|
|
16.629097605893
|
-9-hode-cholesteryl-ester
|
|
atherosclerosis LDL oxidized lipids autoxidation hydroxy fatty acids esters (+/-)9-HODEs (+/-)-HODEs (+/-)HODEs racemic |
16.629097605893
|
| 10705 |
(±)9-HpODE
Exclusive |
|
5502-91-0 |
≥98%
|
|
✓ |
2011-02-15
|
27.151966850828
|
-9-hpode
|
|
lipoxygenases oxylipins hydroperoxides plants defense LDLs inflammation |
27.151966850828
|
| 38420 |
9-OxoODE
|
|
54232-59-6 |
>98%
|
|
|
|
7.364931059331
|
9-oxoode
|
9-KODE
|
9-KODEs metabolites oxo-acids metabolites fatty 9-OxoODEs 9-oxo-ODEs deuterateds deuterium mass spectrometry LC-MS LC/MS reticulocyte mitochondrial plasma membranes lipids LC MS 15-LO OxoODEs 15-lipoxygenase linoleate residues acids oxo-fatty |
7.364931059331
|
| 338420 |
9-OxoODE-d3
New |
|
- |
≥99% deuterated product
|
|
|
2011-11-11
|
6.663195612138
|
9-oxoode-d3
|
9-KODE-d3
|
9-KODEs metabolites oxo-acids metabolites fatty 9-OxoODEs 9-oxo-ODEs deuterateds deuterium mass spectrometry LC-MS LC/MS reticulocyte mitochondrial plasma membranes lipids LC MS 15-LO OxoODEs 15-lipoxygenase linoleate residues acids oxo-fatty |
6.663195612138
|
| 10009215 |
9-OxoOTrE
|
|
125559-74-2 |
>95%
|
|
|
2006-11-01
|
5.783770718231
|
9-oxootre
|
9-KOTrE; 9-KOTE
|
oxidation antimicrobial plants pathogenic microorganisms bacteria fungi fungus hydroperoxides linolenic acids oxylipins 9S-HpOTrEs 9-HpOTrEs 9(S)-HpOTrEs 9(S)HpOTrEs hydroperoxy 5-lipoxygenases fatty 5-LOs |
5.783770718231
|
| 34405 |
9(R)-HETE
Exclusive |
|
107656-14-4 |
≥98%
|
|
✓ |
|
6.390331491713
|
9-r-hete
|
|
hydroxy acids 9R-HETEs 9-HETEs fatty 9(r)-HETEs 9(R)HETEs |
6.390331491713
|
| 38405 |
9(R)-HODE
|
|
10075-11-3 |
≥98%
|
|
|
|
20.029613259668
|
9-r-hode
|
|
linoleic acids hydroxy 9r-HODEs 9-HODEs fatty 9(R)-HODEs 9(R)HODEs autoxidation oxidized |
20.029613259668
|
| 38406 |
9(R)-HODE cholesteryl ester
|
|
- |
≥98%
|
|
|
|
1.087108655617
|
9-r-hode-cholesteryl-ester
|
|
atherosclerosis LDL oxidized lipids autoxidation hydroxy fatty acids esters 9R-HODEs 9-HODEs 9(R)-HODEs 9(R)HODEs |
1.087108655617
|
| 32410 |
9(S)-HEPE
|
|
- |
≥98%
|
|
|
|
4.661243093923
|
9-s-hepe
|
|
hydroxy acids EPA 9S-HEPEs 9(S)-HEPEs 9-HEPEs eicosapentanoic fatty 9(S)HEPES |
4.661243093923
|
| 34410 |
9(S)-HETE
|
|
107656-13-3 |
≥98%
|
|
|
|
7.145856353591
|
9-s-hete
|
|
hydroxy acids 9S-HETEs 9-HETEs fatty 9(S)-HETEs 9(S)HETEs |
7.145856353591
|
| 38410 |
9(S)-HODE
|
|
73543-67-6 |
≥98%
|
|
|
|
19.062651933701
|
9-s-hode
|
|
linoleic acids hydroxy oxidized 9S-HODEs 9-HODEs fatty 9(S)-HODEs 9(S)HODEs |
19.062651933701
|
| 38411 |
9(S)-HODE cholesteryl ester
|
|
- |
≥98%
|
|
|
|
2.153314917127
|
9-s-hode-cholesteryl-ester
|
|
atherosclerosis LDL oxidized lipids hydroxy fatty acids 9-HODEs esters 9S-HODEs 9(S)-HODEs 9(S)HODEs |
2.153314917127
|
| 338410 |
9(S)-HODE-d4
|
|
- |
≥99% deuterated product
|
|
|
|
17.761325966851
|
9-s-hode-d4
|
|
GC/MS deuterium isotopes 9-HODE-d4 standards 9S-HODE-d4 deuterated GC-MS LC/MS LC-MS 9-HODEs 9(S)-HODEs 9S-HODEs 9(S)HODES hydroxy fatty acids 9(S)HODE-d4 mass spectrometry |
17.761325966851
|
| 39420 |
9(S)-HOTrE
|
|
89886-42-0 |
≥98%
|
|
|
|
7.112304656669
|
9-s-hotre
|
|
9s-hotres 9(s)hotres PUFAs polyunsaturated fatty acids hydroxy 5-LOs 5-lipoxygenases 9(s)-hotres |
7.112304656669
|
| 48410 |
9(S)-HpODE
|
|
29774-12-7 |
≥98%
|
|
|
|
11.157513812154
|
9-s-hpode
|
|
linoleic hydroperoxides 9S-HpODEs 9-HpODEs hydroperoxy fatty acids 9(S)-HpODEs colneleic 5-LO 5-lipoxygenases 5LO |
11.157513812154
|
| 45120 |
9(S)-HpOTrE
Exclusive |
|
111004-08-1 |
≥98%
|
|
✓ |
|
6.799149171270
|
9-s-hpotre
|
|
hydroperoxides linolenic acids 9S-HpOTrEs 9-HpOTrEs 9(S)-HpOTrEs 9(S)HpOTrEs hydroperoxy 5-lipoxygenases fatty 5-LOs |
6.799149171270
|
| 10005292 |
Atherosclerosis Product Pack
|
|
- |
|
|
|
2004-09-09
|
4.115082872928
|
atherosclerosis-product-pack
|
|
Acyl-coenzyme A: cholesterol acyltransferase-1 esters ACAT1 atherosclerosis inhibitors inhibits inhibition CETP WB blots blotting IHC immunohistochemistry JTT-705 89450 packs |
4.115082872928
|
| 48001 |
Cholesteryl Linoleate Hydroperoxides
|
|
- |
>98% hydroperoxide content
|
|
|
|
13.910419889502
|
cholesteryl-linoleate-hydroperoxides
|
|
autoxidation atherosclerosis LDL HDL hydroperoxy fatty acids |
13.910419889502
|
| 10710 |
dinor-12-oxo Phytodienoic Acid
Exclusive |
|
197247-23-7 |
≥95%
|
|
✓ |
2011-03-25
|
5.089769797422
|
dinor-12-oxo-phytodienoic-acid
|
dinor-12-oxo PDA; dinor-OPDA
|
jasmonates pathways plants hormones senescence development intermediates jasmonic acids glycerolipids galactolipids arabidopsides dnOPDA dn-OPDA dn-oxo-PDA |
5.089769797422
|
| 10696 |
dinor-12-oxo Phytodienoic Acid-d5
Exclusive |
|
- |
≥99% deuterated product
|
|
✓ |
2011-04-04
|
5.605423572743
|
dinor-12-oxo-phytodienoic-acid-d5
|
dinor-12-oxo PDA-d5; dinor-OPDA-d5
|
jasmonates pathways plants hormones senescence development intermediates jasmonic acids glycerolipids galactolipids arabidopsides dnOPDA dn-OPDA deuterateds deuteriums LC-MS LC/MS GC-MS GC/MS mass spectrometry MS LC GC standards |
5.605423572743
|
| 34265 |
FOG9
|
|
- |
≥98%
|
|
|
|
67.308743093922
|
fog9
|
5-OxoETE-glutathione
|
metabolites chemotactic fatty 5-oxo-etes chemotaxis oxo-acids |
67.308743093922
|
| 34002 |
(±)-HETE HPLC Mixture
|
|
- |
≥98% for each compound
|
|
|
|
10.298097868981
|
-hete-hplc-mixture
|
|
racemic hydroxy acids arachidonic autoxidation (+/-)-HETEs fatty chromatography (+/-)HETEs |
10.298097868981
|
| 44001 |
Hydroperoxy HPLC Mixture
|
|
- |
>98% for each compound
|
|
|
|
19.017384898710
|
hydroperoxy-hplc-mixture
|
|
HPLC 12-HpETEs 5-HpETEs 15-HpETEs hydroperoxides |
19.017384898710
|
| 89420 |
Hydroxy Linoleins
|
|
- |
≥98% (A mixture of 132 isomers)
|
|
|
|
11.253038674032
|
hydroxy-linoleins
|
|
fatty acids trilinoleins autoxidation lipid peroxidation triglycerides |
11.253038674032
|
| 20110 |
Leukotriene B4
|
|
71160-24-2 |
≥97%
|
|
|
|
184.036077348066
|
leukotriene-b4
|
LTB4
|
leukotrienes LTB4 inflammation chemotaxis atherosclerosis |
184.036077348066
|
| 10007240 |
Leukotriene B4 Lipid Maps MS Standard
|
|
71160-24-2 |
≥97%
|
|
|
2009-01-14
|
32.633635359115
|
leukotriene-b4-lipid-maps-ms-standard
|
LTB4
|
leukotrienes LTB4 inflammation chemotaxis atherosclerosis LTs MS mass spectrometry standards |
32.633635359115
|
| 89430 |
Linolein Hydroperoxides
|
|
- |
>98% (A mixture of 132 isomers)
|
|
|
|
11.499815837937
|
linolein-hydroperoxides
|
|
trilinoleins autoxidation atherosclerosis isomers hydroperoxy fatty acids |
11.499815837937
|
| 705002 |
Lipid Hydroperoxide (LPO) Assay Kit
|
|
- |
|
|
|
|
259.771404419889
|
lipid-hydroperoxide-lpo-assay-kit
|
|
lipids peroxidation oxidative injury inflammation free radicals colorimetric hydroperoxides stress atherosclerosis assays |
259.771404419889
|
| 705003 |
Lipid Hydroperoxide (LPO) Assay Kit (96 well)
|
|
- |
|
|
|
|
156.447859116022
|
lipid-hydroperoxide-lpo-assay-kit-96-well
|
|
lipids peroxidation oxidative injury inflammation free radicals colorimetric hydroperoxides stress assays |
156.447859116022
|
| 10011453 |
Lipoxin A5
Exclusive |
|
110657-98-2 |
≥95%
|
|
✓ |
2008-11-17
|
55.738222836095
|
lipoxin-a5
|
LXA5
|
EPAs LXA4 LXB4 smooth muscle contraction lipoxins vasodilatory leukocytes pulmonary parenchymal LXAs |
55.738222836095
|
| 88840 |
n-Triacontanol
|
|
593-50-0 |
>98%
|
|
|
|
1.051104972375
|
n-triacontanol
|
Well-Bloom; Miraculan
|
plants growth regulators |
1.051104972375
|
| 90510 |
O-11
|
|
119290-12-9 |
>98%
|
|
|
2004-07-06
|
64.272762430939
|
o-11
|
11-Oxatetradecanoic Acid
|
myristic acids Trypanosoma brucei parasites protozoans African sleeping sickness Trypanosine inhibitors trypansomes 10-propoxydecanoic variant surface glycoproteins toxic myristate vsg |
64.272762430939
|
| 34004 |
Oxidized Lipid HPLC Mixture
|
|
- |
>98% for each compound
|
|
|
|
17.747636586863
|
oxidized-lipid-hplc-mixture
|
|
ROS peroxidation LDL atherosclerosis autoxidation reactive oxygen species (+/-)9-HODEs (+/-)13-HODEs esters (+/-)15-HETEs (+/-)-HODEs (+/-)-HETEs hydroxy fatty acids racemic (+/-)HODEs (+/-)HETEs cholesteryl esters |
17.747636586863
|
| 75760 |
PPOH
|
|
206052-01-9 |
>99%
|
|
|
|
46.286924493554
|
ppoh
|
|
selective epoxygenases inhibitors inhibits acetylenic fatty acids cytochromes CYP450-4A2 CYP450-4A3 CYP450-4A1 CYP-450-4A2 CYP-450-4A3 CYP-450-4A1 CYP-4A2 CYP-4A1 CYP-4A3 endocrinology |
46.286924493554
|
| 10012554 |
Resolvin D1
Exclusive |
|
872993-05-0 |
≥95%
|
|
✓ |
2008-06-06
|
256.881973164956
|
resolvin-d1
|
RvD1; 17(S)-Resolvin D1
|
EPA DHA inflammation antiinflammatory anti-inflammatory immune responses aspirin LOX peritonitis LOS neurochemistry resolvins |
256.881973164956
|
| 34001 |
(S)-HETE HPLC Mixture
|
|
- |
≥98% for each compound
|
|
|
|
23.352025782688
|
-s-hete-hplc-mixture
|
|
hydroxy acids arachidonic chromatography fatty lipoxygenase 8(S)-HETEs 11(S)-HETEs 12(S)-HETEs 15(S)-HETEs 8S-HETES 11S-HETEs 12S-HETEs 15S-HETEs 8(S)HETEs 11(S)HETEs 12(S)HETEs 15(S)HETEs 8-HETEs 11-HETEs 12-HETEs 15-HETEs |
23.352025782688
|
| 34565 |
tetranor-12(R)-HETE
|
|
135271-51-1 |
≥98%
|
|
|
|
8.966160220994
|
tetranor-12-r-hete
|
8(R)-HHxTrE
|
12-HETEs 12R-HETEs 12(R)-HETEs metabolites beta-oxidation b-oxidation .beta.-oxidation 8(R)HHxTrEs 8R-HHxTrEs 8-HHxTrEs fatty hydroxy acids 12(R)HETEs |
8.966160220994
|
| 10004257 |
trans-4,5-epoxy-2(E)-Decenal
|
|
134454-31-2 |
>95%
|
|
|
2005-03-16
|
51.696828729281
|
trans-4-5-epoxy-2-e-decenal
|
3-(3-pentyloxiranyl)-2E-propenal
|
aldehydes odorant peroxidation oxidative injury PUFAs polyunsaturated fatty acids reactive aldehydes tools peroxidative damages stress |
51.696828729281
|
| 10004224 |
trans-EKODE-(E)-Ib
Exclusive |
|
478931-82-7 |
≥98%
|
|
✓ |
2009-12-22
|
33.876583793738
|
trans-ekode-e-ib
|
12,13-epoxy-9-keto-10(trans)-Octadecenoic Acid
|
oxidative stress linoleic acid peroxidation EKODEs antioxidant response elements AREs neuronal cells NQO1 aldosterone corticosterone adrenal cells calcium stimulated synthesis intercellular |
33.876583793738
|
| 88820 |
Traumatic Acid
|
|
6402-36-4 |
>98%
|
|
|
|
19.940718232044
|
traumatic-acid
|
trans-2-Dodecenedioic Acid
|
acids plants growth regulators hydroperoxide lyase wound healing fatty acids |
19.940718232044
|
| 34003 |
ω-3 Hydroxy Acid HPLC Mixture
|
|
- |
>98% for each compound
|
|
|
|
8.859788213628
|
-3-hydroxy-acid-hplc-mixture
|
|
acids .omega.-3-OH omega-3-OH w-3-OH fatty .omega.-3-hydroxy omega-3-hydroxy w-3-hydroxy 12(S)-HEPEs 15(S)-HEPEs 12(S)HEPEs 15(S)HEPEs 12-HEPEs 15-HEPEs 12S-HEPEs 15S-HEPEs 13(S)-HOTrEs 15(S)-HOTrEs 15S-HETrEs 13-HOTrEs 15-HETrEs lipoxygenases LOs chromatography |
8.859788213628
|